Real-World Comparison of PD-1 and PD-L1 Inhibitor Monotherapy in Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression.

Cancers (Basel) · 2026 · PMC13072067 · PMID 41976377

Europe PMC DOI

hedged sentence

0.5590

closest p · 11.2× alpha

0.5590

boldest claim

The sentences

did not reach statistical significancep = 0.559not close (p > 0.1)

5.33 months), although this difference did not reach statistical significance (HR 1.14, 95% CI 0.74–1.74; p = 0.559).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.